ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+3.78%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$245M
AUM Growth
+$245M
(+11%)
Cap. Flow
-$16.3M
Cap. Flow
% of AUM
-6.64%
Top 10 Holdings %
Top 10 Hldgs %
46.21%
Holding
76
New
23
Increased
14
Reduced
16
Closed
20
Top Buys
| 1 |
Esperion Therapeutics
ESPR
|
$9.4M |
| 2 |
Centene
CNC
|
$8.38M |
| 3 |
Medtronic
MDT
|
$6.95M |
| 4 |
ICU Medical
ICUI
|
$6.55M |
| 5 |
Ocular Therapeutix
OCUL
|
$6.29M |
Top Sells
| 1 |
Hologic
HOLX
|
$22.3M |
| 2 |
Pfizer
PFE
|
$16.7M |
| 3 |
Sanofi
SNY
|
$15.8M |
| 4 |
SI-BONE Inc
SIBN
|
$9.23M |
| 5 |
Cigna
CI
|
$6.62M |
Sector Composition
| 1 | Healthcare | 86.32% |
| 2 | Industrials | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXFD
1
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $18.2M | 1% | 1,396,795 -299,093 | -18% | -$3.89M |
|
|
2
SI-BONE Inc
SIBN
$719M
| $11.8M | 0.65% | 743,380 -578,964 | -44% | -$9.23M |
|
3
Johnson & Johnson
JNJ
$427B
| $11.8M | 0.65% | 83,879 +35,388 | +73% | +$4.98M |
|
|
4
Centene
CNC
$14.3B
| $10.8M | 0.59% | 170,057 +131,861 | +345% | +$8.38M |
|
5
Zoetis
ZTS
$69.3B
| $10M | 0.55% | 73,200 -2,022 | -3% | -$277K |
|
|
6
Esperion Therapeutics
ESPR
$448M
| $9.4M | 0.52% | +183,249 | New | +$9.4M |
|
7
Encompass Health
EHC
$12.3B
| $8.74M | 0.48% | 141,195 +85,581 | +154% | +$5.3M |
|
8
Elevance Health
ELV
$71.8B
| $7.9M | 0.43% | 30,028 -13,323 | -31% | -$3.5M |
|
|
9
Medtronic
MDT
$119B
| $6.95M | 0.38% | +75,828 | New | +$6.95M |
|
|
10
Cigna
CI
$80.3B
| $6.78M | 0.37% | 36,122 -35,306 | -49% | -$6.62M |
|
|
11
ICU Medical
ICUI
$3.15B
| $6.55M | 0.36% | +35,556 | New | +$6.55M |
|
12
Labcorp
LH
$23.1B
| $6.3M | 0.35% | 37,915 +11,571 | +44% | +$1.92M |
|
|
13
Ocular Therapeutix
OCUL
$2.12B
| $6.29M | 0.35% | +755,330 | New | +$6.29M |
|
14
AbbVie
ABBV
$372B
| $6.15M | 0.34% | +62,615 | New | +$6.15M |
|
15
Zimmer Biomet
ZBH
$21B
| $5.5M | 0.3% | 46,038 -48,058 | -51% | -$5.74M |
|
|
TRIL
16
DELISTED
Trillium Therapeutics Inc.
TRIL
| $5.48M | 0.3% | 677,823 +200,119 | +42% | +$1.62M |
|
|
HMSY
17
DELISTED
HMS Holdings Corp.
HMSY
| $5.24M | 0.29% | +161,914 | New | +$5.24M |
|
|
18
Sanofi
SNY
$121B
| $5.1M | 0.28% | 99,869 -310,092 | -76% | -$15.8M |
|
19
Cartesian Therapeutics
RNAC
$261M
| $5.05M | 0.28% | 1,779,328 +1,524,020 | +597% | +$4.33M |
|
|
ADAP
20
Adaptimmune Therapeutics
ADAP
$15.6M
| $4.84M | 0.27% | 483,103 +323,277 | +202% | +$3.24M |
|
|
21
Hologic
HOLX
$14.9B
| $4.66M | 0.26% | 81,789 -391,878 | -83% | -$22.3M |
|
22
Prothena Corp
PRTA
$441M
| $4.22M | 0.23% | 403,793 +147,844 | +58% | +$1.55M |
|
|
HRC
23
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $3.91M | 0.21% | 35,604 +9,364 | +36% | +$1.03M |
|
24
Insmed
INSM
$28.8B
| $3.86M | 0.21% | 140,184 +65,819 | +89% | +$1.81M |
|
25
Boston Scientific
BSX
$156B
| $3.73M | 0.2% | +106,338 | New | +$3.73M |
|